ADMA
ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
2.75 / 10
Underperform
Financial analysis yields inadequate rating (2.8/10). Positive contributors: Days sales outstanding and Interest coverage ratio (EBIT / Interest expense) (%), although drawbacks are visible in PB-ROE and Asset-MV. Concluding evaluation: defensive.
Analysis Checks(7/10)
Revenue-MV
Value-1.11
Score1/3
Weight10.35%
1M Return4.24%
Value-1.11
Score1/3
Weight10.35%
1M Return4.24%
Days sales outstanding
Value68.29
Score2/3
Weight2.24%
1M Return1.10%
Value68.29
Score2/3
Weight2.24%
1M Return1.10%
Net income-Revenue
Value0.57
Score3/3
Weight24.46%
1M Return9.29%
Value0.57
Score3/3
Weight24.46%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value30.53
Score2/3
Weight-2.06%
1M Return-1.11%
Value30.53
Score2/3
Weight-2.06%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight15.04%
1M Return6.68%
Value-0.50
Score1/3
Weight15.04%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value20.10
Score2/3
Weight2.20%
1M Return1.11%
Value20.10
Score2/3
Weight2.20%
1M Return1.11%
Profit-MV
Value0.29
Score2/3
Weight20.56%
1M Return8.45%
Value0.29
Score2/3
Weight20.56%
1M Return8.45%
PB-ROE
Value5.08
Score0/3
Weight6.14%
1M Return2.72%
Value5.08
Score0/3
Weight6.14%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value20.10
Score2/3
Weight0.85%
1M Return0.43%
Value20.10
Score2/3
Weight0.85%
1M Return0.43%
Cash-MV
Value-1.95
Score2/3
Weight20.21%
1M Return8.41%
Value-1.95
Score2/3
Weight20.21%
1M Return8.41%
Revenue-MV
Value-1.11
Score1/3
Weight10.35%
1M Return4.24%
Value-1.11
Score1/3
Weight10.35%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value20.10
Score2/3
Weight2.20%
1M Return1.11%
Value20.10
Score2/3
Weight2.20%
1M Return1.11%
Days sales outstanding
Value68.29
Score2/3
Weight2.24%
1M Return1.10%
Value68.29
Score2/3
Weight2.24%
1M Return1.10%
Profit-MV
Value0.29
Score2/3
Weight20.56%
1M Return8.45%
Value0.29
Score2/3
Weight20.56%
1M Return8.45%
Net income-Revenue
Value0.57
Score3/3
Weight24.46%
1M Return9.29%
Value0.57
Score3/3
Weight24.46%
1M Return9.29%
PB-ROE
Value5.08
Score0/3
Weight6.14%
1M Return2.72%
Value5.08
Score0/3
Weight6.14%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value30.53
Score2/3
Weight-2.06%
1M Return-1.11%
Value30.53
Score2/3
Weight-2.06%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value20.10
Score2/3
Weight0.85%
1M Return0.43%
Value20.10
Score2/3
Weight0.85%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight15.04%
1M Return6.68%
Value-0.50
Score1/3
Weight15.04%
1M Return6.68%
Cash-MV
Value-1.95
Score2/3
Weight20.21%
1M Return8.41%
Value-1.95
Score2/3
Weight20.21%
1M Return8.41%
Is ADMA fundamentally strong?
- ADMA scores 2.75/10 on fundamentals and holds a Premium valuation at present. Backed by its 25.01% ROE, 42.87% net margin, 18.77 P/E ratio, 9.09 P/B ratio, and 206.90% earnings growth, these metrics solidify its Underperform investment rating.
